Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP676063.RAIhUeG1lXuSL89UyPKbVAfXuugHUjsbZwdlskuBsbLzo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP676063.RAIhUeG1lXuSL89UyPKbVAfXuugHUjsbZwdlskuBsbLzo130_assertion type Assertion NP676063.RAIhUeG1lXuSL89UyPKbVAfXuugHUjsbZwdlskuBsbLzo130_head.
- NP676063.RAIhUeG1lXuSL89UyPKbVAfXuugHUjsbZwdlskuBsbLzo130_assertion description "[Results showed that 94.6% (70/74) HCC and 55.6% (10/18) cirrhosis patients with CIMP+ show expression of high telomerase activity than 45.5% (10/22) HCC and 6.25% (1/16) cirrhosis patients with CIMP- (p < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP676063.RAIhUeG1lXuSL89UyPKbVAfXuugHUjsbZwdlskuBsbLzo130_provenance.
- NP676063.RAIhUeG1lXuSL89UyPKbVAfXuugHUjsbZwdlskuBsbLzo130_assertion evidence source_evidence_literature NP676063.RAIhUeG1lXuSL89UyPKbVAfXuugHUjsbZwdlskuBsbLzo130_provenance.
- NP676063.RAIhUeG1lXuSL89UyPKbVAfXuugHUjsbZwdlskuBsbLzo130_assertion SIO_000772 18546260 NP676063.RAIhUeG1lXuSL89UyPKbVAfXuugHUjsbZwdlskuBsbLzo130_provenance.
- NP676063.RAIhUeG1lXuSL89UyPKbVAfXuugHUjsbZwdlskuBsbLzo130_assertion wasDerivedFrom befree-2016 NP676063.RAIhUeG1lXuSL89UyPKbVAfXuugHUjsbZwdlskuBsbLzo130_provenance.
- NP676063.RAIhUeG1lXuSL89UyPKbVAfXuugHUjsbZwdlskuBsbLzo130_assertion wasGeneratedBy ECO_0000203 NP676063.RAIhUeG1lXuSL89UyPKbVAfXuugHUjsbZwdlskuBsbLzo130_provenance.